Boston Scientific (BSX) Inventory (2009 - 2026)

Boston Scientific has disclosed Inventory across 18 years of filings, most recently posting $3.1 billion for Q1 2026.

• Inventory for Q1 2026 came in at $3.1 billion, up 8.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 8.72% YoY), and the FY2025 annual result was $2.9 billion, up 4.73% from the prior year.
• Inventory came in at $3.1 billion for Q1 2026 at Boston Scientific, up from $2.9 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $3.1 billion in Q1 2026 to a low of $1.7 billion in Q1 2022.
• The 5-year median for Inventory is $2.6 billion (2024), against an average of $2.5 billion.
• Across the five-year window, Inventory soared 34.45% in 2023 and rose 4.73% in 2025, its largest moves.
• Boston Scientific's Inventory stood at $1.9 billion in 2022, then surged by 33.05% to $2.5 billion in 2023, then advanced by 13.12% to $2.8 billion in 2024, then climbed by 4.73% to $2.9 billion in 2025, then advanced by 5.91% to $3.1 billion in 2026.
• The last three Inventory figures came in at $3.1 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.9 billion (Q3 2025), per Business Quant data.